Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Prostate Cancer (PCa) in ADT”

4 trials

Showing 4 of 4 results

Large-scale testing (Phase 3)Study completedNCT01020448
What this trial is testing

Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Ipsen 339
Not applicableLooking for participantsNCT06200558
What this trial is testing

ARON-3 Study: International Multicentric Retrospective Study to Collect Global Experiences in the Treatment of Patients With Metastatic PCa

Who this might be right for
Prostate Cancer
Hospital of Macerata 534
Testing effectiveness (Phase 2)Study completedNCT02107391
What this trial is testing

Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
SOTIO a.s. 63
Not applicableStudy completedNCT06238596
What this trial is testing

Rehabilitation Intervention to Prevent Adverse Events Related to Androgen-deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer (PCa): a Single Arm Feasibility Study (ReCaP Study)

Who this might be right for
Metastatic Prostate Cancer (PCa) in ADTRehabilitation
Azienda USL Reggio Emilia - IRCCS 40

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation